Hwail Pharm Co., Ltd. (061250)
KRX SM KRX SM Primary Summary
Hwail Pharm Co., Ltd. (061250) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Hwail Pharm Co., Ltd. ever had a stock split?
Hwail Pharm Co., Ltd. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | - CEO | KRX SM Exchange | - ISIN |
| South Korea Country | - Employees | - Last Dividend | 4 May 2026 Last Split | - IPO Date |
Overview
Founded in 1974, Hwail Pharmaceutical Co., Ltd. is a South Korean company dedicated to the development of pharmaceutical raw materials. Based in Hwaseong-si, South Korea, the company has established itself as a key player in the pharmaceutical industry by providing a broad range of products and services. These include raw drug products, finished drug products, and functional health food raw material business. Over the years, Hwail Pharmaceutical has become known for its commitment to innovation and quality, underpinned by its deep industry expertise and advanced research and development capabilities.
Products and Services
- Raw Drug Products
Hwail Pharmaceutical produces high-quality raw pharmaceutical ingredients used in the formulation of various medicines. These raw materials comply with stringent quality control standards to ensure efficacy and safety in pharmaceutical applications.
- Finished Drug Products
The company also specializes in the manufacture of finished drug products, ready for consumption by patients. These products range from tablets and capsules to topical creams and injections, serving various therapeutic areas.
- Functional Health Food Raw Material Business
Expanding beyond traditional pharmaceuticals, Hwail Pharmaceutical is involved in the functional health food sector. The company provides key raw materials used in the production of health supplements and functional foods designed to support overall wellness and specific health needs.
